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Supplemental Figures 1-5 and Figure Legends 
 
Fig. S1. CH25H suppresses VSV-SARS-CoV-2 replication in HEK293-hACE2 cells.  
(A) HEK293-hACE2-mCherry cells were transfected with plasma membrane (PM)-
localized GFP and stained for cell surface (green), ACE2 (red), nucleus (DAPI, 
blue), and actin (white). Scale bar: 30 µm. 
(B)  Wild-type (WT) HEK293 or HEK293-hACE2-mCherry cells were infected with 
VSV-SARS-CoV-2 (MOI=1) for 8 hr. Scale bar: 200 µm. 
(C) Same as (B) except that infection was 24 hr and RNA was harvested for RT-qPCR 
measuring the mRNA level of VSV N compared to GAPDH expression. 
(D) Same as (B) except that infection was 24 hr and cell lysates were harvested for 
plaque assays. 
(E) HEK293-hACE2 cells stably expressing indicated ISGs were harvested for 
western blot and probed for V5-tagged ISG and GAPDH protein levels. 
(F) HEK293-hACE2 cells stably expressing indicated ISGs were infected with VSV-
SARS-CoV-2 (MOI=1) for 24 hr. Scale bar: 200 µm. 
(G) HEK293 cells were transfected with mock, IFIH1, or CH25H plasmids for 24 hr or 
treated with 25HC (10 µM) for 1 hr. RNA was harvested and the mRNA levels of 
IFN-β (IFNB) and IFN-λ (IFNL3) were measured by RT-qPCR and normalized to 
GAPDH expression. 
(H) HEK293-hACE2-CH25H cells transduced with lentiviruses encoding Cas9 and 
single-guide RNA against CH25H were harvested for Sanger sequencing to 
examine the edited CH25H locus.  
(I) Same as (H) except that western blot was performed instead to examine the 
protein levels of CH25H and GAPDH.  
For all figures, experiments were repeated at least three times with similar results. 
Data are represented as mean ± SEM. Statistical significance is from pooled data 
of the multiple independent experiments (***p≤0.001). 
  
 
Fig. S2. 25HC restricts VSV-SARS-CoV-2 replication in MA104 cells. 
(A) MA104 cells were infected with serially diluted VSV-SARS-CoV-2 with or without 
25HC (10 µM). At 3 dpi, GFP signals were scanned with Typhoon.   
(B) Quantification of plaque sizes in (A). 
(C) Human iPSC-derived cardiomyocytes were treated with 25HC (10 µM) for 1 hr and 
infected with VSV-SARS-CoV-2 (MOI=0.01). GFP signals were detected at 96 hpi. 
Scale bar: 200 µm. 
(D) HEK293-hACE2 cells were transfected with wild-type (WT) or enzymatic mutant 
CH25H for 24 hr. Cell lysates were harvested for western blot examining CH25H 
and GAPDH protein levels. 
(E) HEK293-hACE2 cells were transfected with WT or enzymatic mutant CH25H for 
36 hr. Cell pellets and culture supernatants were harvested for 7-α, 25-diHC mass 
spectrometry. 
For all figures, experiments were repeated at least three times with similar results. 




Fig. S3. CH25H and 25HC block SARS-CoV-2 S mediated fusion.  
(A) HEK293-hACE2-TMPRSS2 cells were infected with wild-type VSV, VSV-SARS-
CoV or VSV-SARS-CoV-2 (MOI=10) for 6 hr. Cells were harvested and measured 
for GFP percentage and intensity by flow cytometry. 
(B) HEK293-hACE2-TMPRSS2 cells expressing eGFP and indicated ISGs or treated 
with 25HC (10 µM) were mixed at 1:1 ratio and co-cultured with HEK293 cells 
expressing SARS-CoV-2 S and TdTomato for 24 hr. Note the formation of cell-cell 
fusion (yellow), highlighted by black arrows. Scale bar: 200 µm. Quantification of 
membrane fusion assays was performed by calculating the yellow signals in the 
images. 
(C) HEK293 cells were co-transfected with eGFP, VSV G, or reovirus FAST p10, with 
or without 25HC (10 µM) for 24 hr. The red arrows highlight the syncytia formation. 
Scale bar: 200 µm. Quantification of membrane fusion assays was performed by 
calculating the number of cells in GFP positive syncytia. 
For all figures, experiments were repeated at least three times with similar results. 
Data are represented as mean ± SEM. Statistical significance is from pooled data 
of the multiple independent experiments (*p≤0.05). 
 
Fig. S4. CH25H and 25HC do not affect S cleavage or lipid raft organization.  
(A) VSV-SARS-CoV-2 (virus) was pre-incubated with 25HC (+, 10 µM) for 30 min and 
used for infection. Alternatively, HEK293-hACE2 cells (cell) were treated with 
25HC (+, 10 µM) for 1 hr and infected with VSV-SARS-CoV-2 (MOI=1). At 6 hpi, 
cells were harvested and measured for GFP percentage and intensity by flow 
cytometry.  
(B) MA104 cells were treated with 25HC (10 µM) based on the scheme (right panel) 
and infected with VSV-SARS-CoV-2 (MOI=1). At 24 hpi, the mRNA level of VSV 
N was measured by RT-qPCR and normalized to GAPDH expression (left panel).  
(C) HEK293-hACE2 cells were transfected with SARS-CoV-2 for 24 hr with or without 
TMPRSS2 and CH25H transfection, trypsin (0.5 µg/ml), or 25HC (10 µM). Cells 
were harvested for western blot and probed for SARS-CoV-2 S1, S2, and GAPDH 
protein levels. FL: full-length SARS-CoV-2 S; S1, S2: S cleavage products. 
(D) HEK293-hACE2 cells stably expressing indicated ISGs were stained for lipid rafts 
(cholera toxin B, green) and nucleus (DAPI, blue). Scale bar: 30 µm. 
(E) MA104 cells were treated with 25HC (0.01-30 µM) or C4-TopFluor-25HC (0.003-
10 µM) for 1 hr and infected with VSV-SARS-CoV-2 (MOI=0.5) for 24 hr.  At 24 hpi, 
the mRNA level of VSV N was measured by RT-qPCR and normalized to GAPDH 
expression and plotted as percentage of inhibition. 
(F) HEK293-hACE2-TMPRSS2 cells were treated with or without C4 TopFluor-25HC 
(F-25HC, 3 µM) and co-cultured at 1:1 ratio with HEK293 cells transfected with 
SARS-CoV-2 and TdTomato for 24 hr. Note that the fused cells (red) stop at the 
boundary of 25HC treated cells (green). Scale bar: 200 µm. 
(G) HEK293-hACE2 cells were transfected GFP-tagged wild-type (WT) or dominant 
negative (DN) mutants of Rab5 or Rab7 for 24 hr. Cells were harvested for western 
blot and probed for GFP and GAPDH protein levels. 
For all figures, experiments were repeated at least three times with similar results. 
Data are represented as mean ± SEM. Statistical significance is from pooled data 
of the multiple independent experiments (***p≤0.001). 
Fig. S5. Inhibition of NPC1 reduced SARS-CoV-2 fusion and infection 
(A) HEK293 cells were incubated with TopFluor-cholesterol (2 µM, green) or C4-
TopFluor-25HC (2 µM, green) for 1 hr and stained with 50 µg/ml filipin for 30 min 
(pseudo-colored in red). Scale bar: 30 µm. 
(B) HEK293-hACE2 cells were treated with ICZ (3 µM) for 16 hr and infected with VSV-
SARS-CoV-2 (MOI=1). At 24 hpi, cell lysates were harvested for TCID50 assays. 
(C) MA104 cells were treated with 25HC at indicated concentrations in either complete 
or serum-free media (SFM) for 1 hr and infected with VSV-SARS-CoV-2 (MOI=1). 
GFP signals at 24 hpi were captured by the fluorescence microscope. 
(D) HEK293-hACE2-TMPRSS2 cells were harvested for western blot and probed for 
NPC1, ACE2, and GAPDH protein levels. 
(E) HEK293-ACE2-TMPRSS2 cells were transfected with SARS-CoV-2 S and 
TdTomato plasmids for 24 hr in the presence of chloroquine (10 µM), camostat (10 
µM), 25HC (20 µM), ICZ (5 µM), or U18666A (5 µM). Scale bar: 200 µm. 
Quantification of membrane fusion assays was performed by calculating the 
number of cells in TdTomato positive syncytia. 
For all figures, experiments were repeated at least three times with similar results. 
Data are represented as mean ± SEM. Statistical significance is from pooled data 
of the multiple independent experiments (*p≤0.05; **p≤0.01). 
  





 Forward  ATGCTGCAATCGTGCTACAA 




 Forward CTGCTTCAAACGATCCACTCAC 
 Reverse TGAATCCATAGACACGCC 
adenovirus 
5 hexon 
Forward  GACATGACTTTCGAGGTCGATCCCATGGA 
 
 Reverse  CCGGCTGAGAAGGGTGTGCGCAGGTA 
 
GAPDH Forward  GGAGCGAGATCCCTCCAAAAT 
 Reverse  GGCTGTTGTCATACTTCTCATGG  
IFNB Forward  ATGACCAACAAGTGTCTCCTCC 
 Reverse  GGAATCCAAGCAAGTTGTAGCTC 
IFNL3 Forward  TAAGAGGGCCAAAGATGCCTT 
 Reverse  CTGGTCCAAGACATCCCCC 
VSV N Forward  GATAGTACCGGAGGATTGACGACTA 
 Reverse  TCAAACCATCCGAGCCATTC 
 




CH25H knockout Sanger sequencing primers: 
 
Forward: CCTCCTACAGTCGCCCTTCT  
Reverse: CAGCGTCACGGGGAACAC  
 





NPC1 CRISPR/Cas9 single-guide RNA: 
 
AAAGAGTTACAATACTACGT 
 
